Generalised Pustular Psoriasis Induced by Cyclosporin A Withdrawal Responding to the Tumour Necrosis Factor Alpha Inhibitor Etanercept

Publisher： Karger

E-ISSN： 1421-9832|205|2|213-216

ISSN： 1018-8665

Source： Dermatology, Vol.205, Iss.2, 2002-08, pp. : 213-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

By  

Dermatology, Vol. 225, Iss. 4, 2012-12 ,pp. : 312-319

Karger

Access to resources Recommend Favorite

Efficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor Blockers

By  

Dermatology, Vol. 219, Iss. 1, 2009-04 ,pp. : 48-53

Karger

Access to resources Recommend Favorite

Etanercept at Different Dosages in the Treatment of Generalized Pustular Psoriasis: A Case Series

By  

Dermatology, Vol. 216, Iss. 4, 2008-02 ,pp. : 355-360

Karger

Access to resources Recommend Favorite

Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa

By  

Case Reports in Dermatology, Vol. 5, Iss. 3, 2013-11 ,pp. : 326-331

Karger

Access to resources Recommend Favorite

Early Videocapillaroscopic Changes of the Psoriatic Skin after Anti-Tumour Necrosis Factor Alpha Treatment

By  

Dermatology, Vol. 210, Iss. 3, 2005-04 ,pp. : 241-243

Karger

Access to resources Recommend Favorite